<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 42 - THE PUBLIC HEALTH AND WELFARE</title></head><body>
<span style="font-weight:bold;font-size:12pt;">42 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 1998 Edition</span><br/>
<span style="font-size:10pt">Title 42 - THE PUBLIC HEALTH AND WELFARE</span><br/>
<span style="font-size:10pt">CHAPTER 6A - PUBLIC HEALTH SERVICE</span><br/>
<span style="font-size:10pt">SUBCHAPTER VII - AGENCY FOR HEALTH CARE POLICY AND RESEARCH</span><br/>
<span style="font-size:10pt">Part A - Establishment and General Duties</span><br/>
<span style="font-size:10pt">Sec. 299a-3 - Demonstration program regarding centers for education and research on therapeutics</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:42_299a-3  usckey:420000000029900000000000a00030000 currentthrough:19990105 documentPDFPage:572 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER VII/Part A/Sec. 299a-3 -->
<!-- itemsortkey:420ABBT -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER VII-AGENCY FOR HEALTH CARE POLICY AND RESEARCH!@!Part A-Establishment and General Duties!@!Sec. 299a-3 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;299a&ndash;3. Demonstration program regarding centers for education and research on therapeutics</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">The Secretary, acting through the Administrator and in consultation with the Commissioner of Food and Drugs, shall establish a demonstration program for the purpose of making one or more grants for the establishment and operation of one or more centers to carry out the activities specified in subsection (b) of this section.</p>
<h4 class="subsection-head">(b) Required activities</h4>
<p class="statutory-body">The activities referred to in subsection (a) of this section are the following:</p>
<p class="statutory-body-1em">(1) The conduct of state-of-the-art clinical and laboratory research for the following purposes:</p>
<p class="statutory-body-2em">(A) To increase awareness of&mdash;</p>
<p class="statutory-body-3em">(i) new uses of drugs, biological products, and devices;</p>
<p class="statutory-body-3em">(ii) ways to improve the effective use of drugs, biological products, and devices; and</p>
<p class="statutory-body-3em">(iii) risks of new uses and risks of combinations of drugs and biological products.</p>
<br class="Q04" />
<p class="statutory-body-2em">(B) To provide objective clinical information to the following individuals and entities:</p>
<p class="statutory-body-3em">(i) Health care practitioners or other providers of health care goods or services.</p>
<p class="statutory-body-3em">(ii) Pharmacy benefit managers.</p>
<p class="statutory-body-3em">(iii) Health maintenance organizations or other managed health care organizations.</p>
<p class="statutory-body-3em">(iv) Health care insurers or governmental agencies.</p>
<p class="statutory-body-3em">(v) Consumers.</p>
<br class="Q04" />
<p class="statutory-body-2em">(C) To improve the quality of health care while reducing the cost of health care through&mdash;</p>
<p class="statutory-body-3em">(i) the appropriate use of drugs, biological products, or devices; and</p>
<p class="statutory-body-3em">(ii) the prevention of adverse effects of drugs, biological products, and devices and <!-- PDFPage:573 -->the consequences of such effects, such as unnecessary hospitalizations.</p>
<br class="Q04" />
<p class="statutory-body-1em">(2) The conduct of research on the comparative effectiveness and safety of drugs, biological products, and devices.</p>
<p class="statutory-body-1em">(3) Such other activities as the Secretary determines to be appropriate, except that the grant may not be expended to assist the Secretary in the review of new drugs.</p>
<h4 class="subsection-head">(c) Application for grant</h4>
<p class="statutory-body">A grant under subsection (a) of this section may be made only if an application for the grant is submitted to the Secretary and the application is in such form, is made in such manner, and contains such agreements, assurances, and information as the Secretary determines to be necessary to carry out this section.</p>
<h4 class="subsection-head">(d) Peer review</h4>
<p class="statutory-body">A grant under subsection (a) of this section may be made only if the application for the grant has undergone appropriate technical and scientific peer review.</p>
<h4 class="subsection-head">(e) Authorization of appropriations</h4>
<p class="statutory-body">For the purpose of carrying out this section, there are authorized to be appropriated $2,000,000 for fiscal year 1998, and $3,000,000 for each of fiscal years 1999 through 2002.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title IX, &sect;905, as added Pub. L. 105&ndash;115, title IV, &sect;409, Nov. 21, 1997, 111 Stat. 2371.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:effectivedate-note -->
<h4 class="note-head">Effective Date</h4>
<p class="note-body">Section effective 90 days after Nov. 21, 1997, except as otherwise provided, see section 501 of Pub. L. 105&ndash;115, set out as an Effective Date of 1997 Amendment note under section 321 of Title 21, Food and Drugs.</p>
<!-- field-end:effectivedate-note -->
<!-- field-end:notes -->


</body></html>